Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.
Maggie Banys-Paluchowski, Steffi Hartmann, Timo Basali, Maria Luisa Gasparri, Jana de Boniface, Oreste Davide Gentilini, Güldeniz Karadeniz Cakmak, Nina Ditsch, Elmar Stickeler, Ellen Schlichting, Isabel Rubio, Florentia Peintinger, Michael Untch, Christine Mau, Frederike Klaassen Federspiel, Susanne Bucher, Kerstin Ramaker, Peter Paluchowski, Lelia Bauer, Sabine Riemer, Dagmar Langanke, Tanja Durpektova Leuf, Jens Schnabel, Ekkehard von Abel, Christine Solbach, Sonja Cáradenas Ovalle, Kerstin Hilmer, Vesna Bjelic-Radisic, Nicole Stahl, Jose I Sanchez-Mendez, Vibeke Hagen, Marit Helene Hansen, Natalia Krawczyk, Bilge Aktas Sezen, Katharina Jursik, Marc Thill, Hans-Christian Kolberg, Toralf Reimer, Franziska Ruf, Kristina Wihlfahrt, Angelika Rief, Tomasz Berger, Esther Schmidt, Nikolas Tauber, Sarah Fröhlich, Thorsten Kühn
{"title":"Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.","authors":"Maggie Banys-Paluchowski, Steffi Hartmann, Timo Basali, Maria Luisa Gasparri, Jana de Boniface, Oreste Davide Gentilini, Güldeniz Karadeniz Cakmak, Nina Ditsch, Elmar Stickeler, Ellen Schlichting, Isabel Rubio, Florentia Peintinger, Michael Untch, Christine Mau, Frederike Klaassen Federspiel, Susanne Bucher, Kerstin Ramaker, Peter Paluchowski, Lelia Bauer, Sabine Riemer, Dagmar Langanke, Tanja Durpektova Leuf, Jens Schnabel, Ekkehard von Abel, Christine Solbach, Sonja Cáradenas Ovalle, Kerstin Hilmer, Vesna Bjelic-Radisic, Nicole Stahl, Jose I Sanchez-Mendez, Vibeke Hagen, Marit Helene Hansen, Natalia Krawczyk, Bilge Aktas Sezen, Katharina Jursik, Marc Thill, Hans-Christian Kolberg, Toralf Reimer, Franziska Ruf, Kristina Wihlfahrt, Angelika Rief, Tomasz Berger, Esther Schmidt, Nikolas Tauber, Sarah Fröhlich, Thorsten Kühn","doi":"10.1007/s10549-025-07635-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Surgical staging procedures of the axilla in initially clinically node-positive (cN +) breast cancer patients receiving neoadjuvant chemotherapy (NACT) vary across countries. Different procedures such as axillary lymph node dissection, sentinel lymph node biopsy, target lymph node biopsy and targeted axillary dissection are currently in use. To date, data on radar reflectors as a non-wire and non-radioactive technique for marking target lymph nodes are limited. The present study aims at examining the detection rate, the rate of lost markers, and magnetic resonance imaging artifacts after TLN marking using a radar reflector before NACT in the largest available cohort of breast cancer patients enrolled in the international prospective AXSANA study.</p><p><strong>Methods: </strong>AXSANA (EUBREAST-03) is an international prospective cohort study including cN + patients managed with different surgical axillary staging techniques after NACT. Eligible patients have cT1-4c cN + breast cancer and receive neoadjuvant chemotherapy. Patients are followed up for 5 years. In the present subgroup analysis, only patients with a TLN marked by a radar reflector were included.</p><p><strong>Results: </strong>A TLN was marked by radar reflector insertion in 158 patients prior to NACT. Of these, 136 had final surgery results available at the time of analysis, and in 135 out of these 136 patients, localization of TLN was attempted. All radar markers were successfully removed. While lymphoid tissue corresponding to the TLN was identified in 132 patients (97.8%), no lymphoid tissue was detected on histopathology in three patients. It remains unclear whether the TLN was excised in these cases or not. In 1 out of 27 patients (3.7%) who underwent preoperative MRI, image assessment was compromised due to artifacts after radar marker placement.</p><p><strong>Conclusion: </strong>To the best of our knowledge, this is the largest prospective series of patients receiving a radar reflector for the marking of a TLN prior to NACT for breast cancer. Our data demonstrate that radar reflectors are a reliable tool for marking target lymph nodes before neoadjuvant treatment.</p><p><strong>Trial registration number: </strong>NCT04373655 (date of registration May 4, 2020).</p>","PeriodicalId":9133,"journal":{"name":"Breast Cancer Research and Treatment","volume":" ","pages":"203-211"},"PeriodicalIF":3.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Cancer Research and Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10549-025-07635-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/20 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Surgical staging procedures of the axilla in initially clinically node-positive (cN +) breast cancer patients receiving neoadjuvant chemotherapy (NACT) vary across countries. Different procedures such as axillary lymph node dissection, sentinel lymph node biopsy, target lymph node biopsy and targeted axillary dissection are currently in use. To date, data on radar reflectors as a non-wire and non-radioactive technique for marking target lymph nodes are limited. The present study aims at examining the detection rate, the rate of lost markers, and magnetic resonance imaging artifacts after TLN marking using a radar reflector before NACT in the largest available cohort of breast cancer patients enrolled in the international prospective AXSANA study.
Methods: AXSANA (EUBREAST-03) is an international prospective cohort study including cN + patients managed with different surgical axillary staging techniques after NACT. Eligible patients have cT1-4c cN + breast cancer and receive neoadjuvant chemotherapy. Patients are followed up for 5 years. In the present subgroup analysis, only patients with a TLN marked by a radar reflector were included.
Results: A TLN was marked by radar reflector insertion in 158 patients prior to NACT. Of these, 136 had final surgery results available at the time of analysis, and in 135 out of these 136 patients, localization of TLN was attempted. All radar markers were successfully removed. While lymphoid tissue corresponding to the TLN was identified in 132 patients (97.8%), no lymphoid tissue was detected on histopathology in three patients. It remains unclear whether the TLN was excised in these cases or not. In 1 out of 27 patients (3.7%) who underwent preoperative MRI, image assessment was compromised due to artifacts after radar marker placement.
Conclusion: To the best of our knowledge, this is the largest prospective series of patients receiving a radar reflector for the marking of a TLN prior to NACT for breast cancer. Our data demonstrate that radar reflectors are a reliable tool for marking target lymph nodes before neoadjuvant treatment.
Trial registration number: NCT04373655 (date of registration May 4, 2020).
期刊介绍：
Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
